HOUSTON, TX - April 1, 2025 (NEWMEDIAWIRE) - Neutra Corp (OTC: NTRR), a company dedicated to advancing life sciences, has executed a Letter of Intent (LOI) to acquire CuraConnector.com, Inc. in stock for stock transaction, marking a strategic move to expand into the healthcare information technology and life sciences sector. This planned acquisition aligns with Neutra Corp’s evolving vision of equipping individuals with the tools necessary to make well-informed, personalized health decisions.
As part of its planned continued expansion, Neutra Corp seeks to integrate innovative technologies into its portfolio, reinforcing its commitment to enhancing health and wellness solutions. The acquisition of CuraConnector.com represents a pivotal step in establishing a dedicated healthcare information technology and life sciences vertical within the company’s operations, positioning itself into future macroeconomic growth sectors.
"This agreement reflects our commitment to advancing life sciences by leveraging healthcare information technology to empower individuals with better healthcare insights to make personal healthcare decisions," said Sydney Jim, President and CEO of Neutra Corp. "By bringing CuraConnector.com into our ecosystem, we are strengthening our ability to provide cutting-edge solutions that support informed health decisions."
Nhan Nguyen, MD, JD, Chairman & Co-Founder of CuraConnector.com, expressed enthusiasm about the collaboration: "We see an incredible opportunity between CuraConnector.com and Neutra Corp. Our shared vision for empowering individuals with better healthcare choices creates a strong foundation for innovation in growing healthcare sectors. This acquisition represents a positive step in expanding the impact of personalized healthcare technology and out potential ability to raise capital for growth and expansion. We look forward to finalizing deal terms and integrating roles within the larger company structure."
The LOI marks the first step in the acquisition process, with both companies working toward finalizing terms and completing due diligence. Further details will be announced as the transaction progresses.
About Neutra Corp
Neutra Corp is a health and wellness company dedicated to advancing life sciences, clinical research, and innovative consumer health solutions. With a diversified portfolio, Neutra Corp focuses on life sciences technology, clinical research, and high-quality wellness products designed to support overall health and well-being.
Committed to empowering individuals with the tools and knowledge needed to make informed healthcare decisions, Neutra Corp integrates cutting-edge research with real-world applications. Its expansion into life sciences and clinical research reinforces its mission to drive innovation in healthcare, while its wellness product line provides natural solutions for consumers seeking alternative wellness options.
Through strategic acquisitions and partnerships, Neutra Corp continues to grow its impact in the life sciences and health sectors, bridging the gap between research, technology, and consumer wellness. For investing, information and performance data, please visit https://www.neutrainc.com.
About CuraConnector.com, Inc.
CuraConnector.com, Inc. is a healthcare technology & digital company with a patent pending technology platform, www.curaconnector.com, that is streamlining how outpatient care is delivered and supplied. The technology helps patients and companies find the exact care provider through a proprietary algorithm that matches on over fifty quantitative and qualitative variables in real time. Through this platform, CuraConnect.com, Inc. is empowering patients, providers, and companies in their individual healthcare needs and decisions and is making a stronger and more efficient healthcare delivery systems for all stakeholders in healthcare.
For more information, please visit: www.curaconnector.com or info@curaconnector.com
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, a description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.
View the original release on www.newmediawire.com
